Mounjaro targets both GIP and GLP-1 receptors (dual action), while Wegovy targets only GLP-1 (single action)
Other important safety information Do not use GLP-1s if you have a personal or family history of medullary thyroid carcinoma (MTC), multiple endocrine neoplasia syndrome 2 (MEN2), or pancreatitis
Retrieved from DailyMed WEGOVY- semaglutide injection, solution
However, patients who've established sustainable eating and exercise patterns often maintain much of their weight loss even after discontinuing medication
Weight loss isnt perfectly linear (because bodies arent spreadsheets), and having medical guidance makes adjustments feel far less frustrating
On the other hand, glutathione acts as an antioxidant by quenching ROS and is involved in the ascorbateglutathione cycle that eliminates damaging peroxides